Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Sarana Meditama Metropolitan Tbk. (SAME)

UBC Medical Indonesia Tbk.Trading
Sarana Meditama Metropolitan Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Sarana Meditama Metropolitan Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Sarana Meditama Metropolitan Tbk. diperdagangkan di Rp308 (kapitalisasi pasar 5,25 T, volume 24 jam 493 rb). Perbedaan utamanya: Sarana Meditama Metropolitan Tbk. jauh lebih besar — sekitar 9,1× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 493 rb). Mana yang lebih baik tergantung tujuan investasimu.

LABSSAME
Kapitalisasi Pasar
576,7 M5,25 T
Volume
3,48 jt493 rb
Lot
34,82 rb4,93 rb
Perputaran
522,79 jt150,64 jt
Harga Rata-rata
150,13305,56
Nilai Transaksi
522,79 jt150,64 jt
Harga Ekuilibrium Indikatif
148308
Volume Ekuilibrium Indikatif
35080

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
SAME
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Sarana Meditama Metropolitan Tbk.

PT Sarana Meditama Metropolitan (the Company) was established based on Notarial Deed No. 27 of Budiarti Karnadi, S.H., dated November 13, 1984

Selengkapnya di halaman SAME